Important lessons in the story of RNAi and Alnylam and their broader implications will be shared.
From January 2012: Pancreatic Cancer. Learn more about pancreatic cancer from a clinical perspective.
A broad-based capacity for experimentation is critical for organizations to succeed because the systems in which people are embedded are increasingly complex and fast.
By helping biologists turn their hunches into rigorous mathematical models, Polina Golland builds software that interprets medical images. Read more about Golland's work at http://web.mit.edu/newsoffice/2012/profile-golland-0112.html
A computational biologist and physician, Collin Stultz takes a unique approach to studying diseases that could lead to new treatments.
Yang presents her work at EmTech 2011: Reprogramming stem cells to repair blood vessels Stanford University Injury and disease can damage blood vessels. But Fan Yang, a Stanford professor of bioengineering and orthopedic surgery, has developed
Bettinger describes his work at EmTech 2011: Tailoring polymers for biodegradable implants Carnegie Mellon University As a graduate student at MIT, Christopher Bettinger created strong, rubbery polymers that mimic natural tissue and can be tail
Professor James G. Fujimoto of MIT discusses research and education in his group, and the intellectual challenges facing engineers at the frontiers of optics and biomedical imaging.
"The Doctor is IN" is a monthly seminar series at the Koch Institute at MIT. The goal of this seminar is to discuss the clinical management of different cancer types.
Phillips describes his work at EmTech 2011: Computer-assisted genetic engineering Microsoft Research Synthetic biology offers the prospect of engineering microbes to fight disease or produce biofuels, but designing the necessary DNA instructions is normally an arduous task. With software ...
Aiming for breakthroughs in the fight against Alzheimer’s disease, diabetes and other major illnesses, MIT and the pharmaceutical firm Pfizer Inc. held a formal groundbreaking for a new, multidisciplinary research center to be built on MIT property in the Kendall Square neighborhood. The ...
CDI scientists explain how they made David Ewing Duncan's beating heart cells in a petri dish and why it's a significant feat.
How Cellular Dynamics International is commercializing the new technology of induced pluripotent stem cells.
Biologist James Thompson and others discuss the discovery of IPS cells: the science and the potential for research and personalized medicine.
Jeff Hrkach and Greg Troiano of BIND Biosciences explain how they make drug-delivering nanoparticles.
10/22/2009 4:00 PM 26"100Ed Scolnick, Director, Psychiatric Disease Program and the Stanley Center for Psychiatric Research, Broad InstituteDescription: An exemplar of the purpose"driven life in medical science, Ed Scolnick details research milestones from a ...
This video illustrates how estrogen is extracted from a drop of human blood using a novel microfluidics chip developed at the University of Toronto. The samples are lysed, and then the estrogen is extracted into a polar solvent (methanol), while the unwanted parts of the blood sample are ...
Gil Alterovitz, a research fellow at Harvard Medical School, translated populations of genes into musical notes. Each constellation (green) represents a key network of interrelated genes (blue). Each network is represented by a musical note. In healthy cells, the notes form music in harmony, ...
Frank L. Douglas, Executive Director, MIT Center for Biomedical Innovation; Professor of the Practice; Una Ryan, President & CEO, AVANT Immunotherapeutics, Inc.; Robert Tepper, President, Research and Development ; Millennium Pharmaceuticals; John A. Fallon, Chief ...
Participants: Isaac S. Kohane, Director, Children's-HST Informatics Program; Associate Director of Bioinformatics, Harvard Partners Center for Genetics and Genomics; Nevine Zariffa, Therapy Area Director, Cardiovascular and Metabolism, Biomedical Data Sciences, ...